Project Grant R21CA293440
Award Date
7/15/24
Completion Date
6/30/26
Dollars Obligated
$426K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Tampa, FL 33612, USA
Similar Awards
The National Cancer Institute (NCI) awarded a Project Grant under the Cancer Treatment Research program (CFDA 93.395) to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The $1,334,592 grant, awarded on May 1, 2024, will fund a 5-year research project to define the impact of in situ activation of CD40 and type 1 interferon signaling on the tumor microenvironment and systemic T cell immunity in murine models and cancer patients. The project aims to advance...
This $995,267 federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports cancer research initiatives at the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The grant will enable the cancer center, a National Cancer Institute-designated comprehensive facility, to conduct critical translational research and clinical trials focused on advancing cancer prevention,...
The U.S. Department of Defense's Defense Health Agency awarded a $481,749 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center) under the Military Medical Research and Development program (CFDA 12.420). The grant, effective September 30, 2023 through September 29, 2026, will support research to dissect the spatial molecular architecture of the transformed cutaneous T cell lymphoma tumor microenvironment, with the goal of identifying novel...
The National Cancer Institute (NCI) awarded a $657,121 Project Grant (CFDA 93.395 - Cancer Treatment Research) to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, FL. The project aims to evaluate the use of polarized conventional type I dendritic cell (cDC1) therapy, primed with HER2 and HER3 antigens, as a potential treatment and prevention strategy for leptomeningeal disease (LMD) in breast cancer patients. The research team will determine the cellular and...
This federal Project Grant award, valued at $168,500.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research conducted by the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida, to cotarget Type 1 PRMTS and YAP1 in order to combat EGFR-mutant lung adenocarcinoma. The grant period runs from September 1, 2024 to August 31, 2025. The Moffitt Cancer Center is a nonprofit,...
The National Institute of Standards and Technology (NIST) awarded a $2,440,000 Project Grant (CFDA 11.617 - Congressionally-Identified Projects) to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, FL. The purpose of this grant is to fund the acquisition of high-precision microscopes to image cells deep within tumor models. These microscopes will allow the researchers to detect and measure millions of cells within a single tumor, providing data on the...
The National Cancer Institute (CFDA 93.396 Cancer Biology Research) awarded a $485,494 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The grant, titled "Interrogating the Relationship Between Translational Dynamics and Non-Canonical Antigen Presentation in Lung Cancer," aims to understand the mechanisms by which non-canonical antigens derived from novel unannotated open reading frames (NUORFs) are presented on Major...
The National Cancer Institute (NCI) awarded a $433,256 Project Grant (CFDA 93.395 - Cancer Treatment Research) to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, FL. The grant aims to investigate a novel treatment strategy for melanoma by targeting a metabolic vulnerability involving the enzyme PHGDH. The research will use genetic and pharmacological approaches to evaluate the therapeutic potential of combining BRAF/MAPK inhibition with dietary serine restriction...
This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Treatment Research program (CFDA 93.395), provides $433,256 to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The funding supports research to identify novel targets and develop lead compounds to overcome resistance to KRAS inhibitors for lung, colon, and other cancers. The project leverages fragment-based chemoproteomics approaches to probe biological target...
The federal Project Grant award, with ID HT94252510232, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $1,619,065.00 grant, awarded on April 15, 2025, supports the "DYNAMIC: DEVELOPMENT OF A BEHAVIORAL INTERVENTION FOR YOUNG ADULTS WITH ADVANCED CANCER" project conducted by the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The project aims to develop and evaluate a...